RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Charlotte Vines to Receptors, CCR7

This is a "connection" page, showing publications Charlotte Vines has written about Receptors, CCR7.
Connection Strength

2.184
  1. Bill CA, Allen CM, Vines CM. C-C Chemokine Receptor 7 in Cancer. Cells. 2022 02 14; 11(4).
    View in: PubMed
    Score: 0.853
  2. Shannon LA, McBurney TM, Wells MA, Roth ME, Calloway PA, Bill CA, Islam S, Vines CM. CCR7/CCL19 controls expression of EDG-1 in T cells. J Biol Chem. 2012 Apr 06; 287(15):11656-64.
    View in: PubMed
    Score: 0.427
  3. Shannon LA, Calloway PA, Welch TP, Vines CM. CCR7/CCL21 migration on fibronectin is mediated by phospholipase Cgamma1 and ERK1/2 in primary T lymphocytes. J Biol Chem. 2010 Dec 10; 285(50):38781-7.
    View in: PubMed
    Score: 0.388
  4. Byers MA, Calloway PA, Shannon L, Cunningham HD, Smith S, Li F, Fassold BC, Vines CM. Arrestin 3 mediates endocytosis of CCR7 following ligation of CCL19 but not CCL21. J Immunol. 2008 Oct 01; 181(7):4723-32.
    View in: PubMed
    Score: 0.338
  5. Flores-Montoya MG, Bill CA, Vines CM, Sobin C. Early chronic low-level lead exposure reduced C-C chemokine receptor 7 in hippocampal microglia. Toxicol Lett. 2019 Oct 10; 314:106-116.
    View in: PubMed
    Score: 0.178
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support